AI and Autonomy AI helps NHS cut lung cancer scan review times in half The government said AI-powered X-ray tools are already available in roughly half of NHS trusts across England Joseph Morton4 days ago
Medical and Pharmaceutical Cancer protein found to self-activate, reshaping understanding of tumor growth The finding challenges long-standing assumptions about how RET-related cancers develop Joseph MortonMay 1, 2026
Health & Wellness Mayo Clinic study shows robotic tech improves early lung cancer diagnosis The system also integrates endobronchial ultrasound to examine nearby lymph nodes Joseph MortonApril 8, 2026
AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph MortonMarch 27, 2026
Medical and Pharmaceutical Early detection breakthrough means pancreatic cancer could be diagnosed in minutes The condition ranks as a major cause of cancer mortality worldwide Joseph MortonNovember 3, 2025
Medical and Pharmaceutical University of Warwick uses diamonds to help trace metastasis in cancer The Warwick team designed a highly sensitive sensor using a diamond measuring just half a cubic millimetre Joseph MortonAugust 22, 2025
AI and Autonomy New artificial intelligence tech allows for digital mapping of tumours iSeg uses 3D imagery to provide a deeper understanding of tumours Joseph MortonJuly 7, 2025
AI and Autonomy Qure.ai offers artificial intelligence training in US to transform clinical operations The initiative helps to advance AI adoption while supporting ongoing learning for radiologic professionals across the country Joseph MortonJune 13, 2025
Health & Wellness Quest Diagnostics and University of Texas want to promote more cancer screenings Quest plans to refine, expand, and validate the MCaST technology for its own lab-developed test Joseph MortonJune 11, 2025
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph MortonMay 27, 2025